Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Klein

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Cell Reports. Medicine|July 8, 2025
Neutralization of acyl coenzyme A binding protein for the experimental prevention and treatment of hepatocellular carcinomaSijing Li, Omar Motiño, Flavia Lambertucci, et al.
Nature Medicine|May 27, 2020
Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancerMaria Paula Roberti, Satoru Yonekura, Connie P M Duong, et al.
The Lancet. Oncology|November 11, 2023
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective studyQinghe Zeng, Christophe Klein, Stefano Caruso, et al.
Science (New York, N.Y.)|November 4, 2017
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumorsBertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa, et al.
Nature Communications|December 13, 2023
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinomaJulien Calderaro, Narmin Ghaffari Laleh, Qinghe Zeng, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Cell Reports. Medicine|July 8, 2025
Neutralization of acyl coenzyme A binding protein for the experimental prevention and treatment of hepatocellular carcinomaSijing Li, Omar Motiño, Flavia Lambertucci, et al.
Nature Medicine|May 27, 2020
Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancerMaria Paula Roberti, Satoru Yonekura, Connie P M Duong, et al.
The Lancet. Oncology|November 11, 2023
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective studyQinghe Zeng, Christophe Klein, Stefano Caruso, et al.
Science (New York, N.Y.)|November 4, 2017
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumorsBertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa, et al.
Nature Communications|December 13, 2023
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinomaJulien Calderaro, Narmin Ghaffari Laleh, Qinghe Zeng, et al.
Pageof 7